Shanghai TTM-Bio Technology Co., Ltd
1 clinical trials · Sponsor
◉ Watch Shanghai TTM-Bio Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101 (NCT07178327) | Shanghai TTM-Bio Technology Co., Ltd | 2025-09-06 |
Track Shanghai TTM-Bio Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.